A 30 yr old male presents to the OPD with Erectile dysfunction. Basic screening evaluation is unremarkable. Which of the following should be the next step in the evaluation/management of this patient?
## **Core Concept**
Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. The etiology can be psychological, organic (including vascular, neurological, hormonal, and cavernosal factors), or a combination of both. A stepwise approach to evaluation helps in identifying the cause and guiding management.
## **Why the Correct Answer is Right**
The correct approach involves a thorough history, physical examination, and initial laboratory tests. If the basic screening evaluation is unremarkable, the next step often involves assessing nocturnal penile tumescence (NPT) or more commonly, evaluating hormonal status, particularly testosterone levels, and considering a trial of phosphodiesterase type 5 (PDE5) inhibitors. However, without specific details on the provided options, a common next step is to check **serum testosterone levels** to rule out hypogonadism, which is a known and treatable cause of ED.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Without specifics, it's hard to directly refute, but if it involves invasive testing not initially indicated, it would be incorrect.
- **Option B:** Similarly, if it suggests immediate complex or invasive procedures without initial conservative management or basic lab tests, it would be premature.
- **Option C:** If this option suggests a treatment trial (like PDE5 inhibitors) without further evaluation, while reasonable, might not be the best initial step if the goal is evaluation before management.
- **Option D:** Assuming this is not the correct answer based on the prompt.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that ED can be an early marker of cardiovascular disease. Hence, risk factors for cardiovascular disease, such as hypertension, diabetes, and smoking, should be assessed. Also, recall that sildenafil (a PDE5 inhibitor) is contraindicated in patients taking nitrates.
## **Correct Answer: B.**